Radius Health Announces Third Quarter 2019 Results and Corporate Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq hits intraday record high on Alphabet boost, Mideast negotiation hopes
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
- Oil falls to two-week low as Gulf supply outlook improves
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Radius Health (RDUS) Tops Q3 EPS by 38c; Raises FY19 Sales Outlook
November 5, 2019 4:25 PM ESTRadius Health (NASDAQ: RDUS) reported Q3 EPS of ($0.44), $0.38 better than the analyst estimate of ($0.82). Revenue for the quarter came in at $46.77 million versus the consensus estimate of $45.69 million.
I am very pleased with our continued strong performance with TYMLOS. We are on a path to make TYMLOS the treatment of choice for high... More
